Skip to main content

Table 1 The prevalence characteristics of three glucose group

From: Advanced glycation end products and diabetes and other metabolic indicators

 

Normal

Impaired glucose tolerance(IGT)

DM

χ2 value

Age

 < 65

541(82.80%)

63(9.60%)

49(7.50%)

20.11**

 ≥ 65

173(71.50%)

27(11.20%)

42(17.40%)

 

Gender

5.23

 Male

378(77.50%)

59(12.10%)

51(10.50%)

 

 Female

345(82.50%)

32(7.70%)

41(9.80%)

 

BMI

12.20**

 Normal

402(83.60%)

41(8.50%)

38(7.90%)

 

 Overweight

257(76.90%)

39(11.70%)

38(11.40%)

 

 Obesity

64(71.10%)

10(11.10%)

16(17.80%)

 

HDL

 Normal

669(80.00%)

85(10.20%)

82(9.80%)

1.51

 Abnormal

54(77.10%)

6(8.60%)

10(14.30%)

 

UA

2.69

 Normal

542(80.70%)

61(9.10%)

69(10.30%)

 

 Abnormal

181(77.40%)

30(12.80%)

23(9.80%)

 

TC

2.28

 Normal

624(80.00%)

81(10.40%)

75(9.60%)

 

 Abnormal

99(78.60%)

10(7.90%)

17(13.50%)

 

TG

6.23*

 Normal

518(82.00%)

58(9.20%)

56(8.90%)

 

 Abnormal

205(74.80%)

33(12.00%)

36(13.10%)

 

SBP

27.72**

 Normal

577(83.40%)

64(9.20%)

51(7.40%)

 

 Abnormal

143(68.40%)

27(12.90%)

39(18.70%)

 

AGE

37.95**

 ≤ P25

193(84.60%)

23(10.10%)

12(5.30%)

 

 P25–P50

191(84.90%)

23(10.20%)

11(4.90%)

 

 P50–P75

177(77.60%)

27(11.80%)

24(10.50%)

 

 > P75

162(72.00%)

18(8.00%)

45(20.00%)

 
  1. *P < 0.05
  2. **P < 0.01